Misfeldt Dayton 4
4 · SUNESIS PHARMACEUTICALS INC · Filed Jul 2, 2019
Insider Transaction Report
Form 4
Misfeldt Dayton
Director10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2019-06-28+480,000→ 480,000 totalExercise: $0.73Exp: 2029-06-28→ Common Stock (480,000 underlying) - Award
Stock Option (Right to Buy)
2019-06-28+60,000→ 60,000 totalExercise: $0.73Exp: 2029-06-28→ Common Stock (60,000 underlying)
Footnotes (2)
- [F1]The option shall vest and become exercisable in twelve (12) equal monthly installments over a one (1) year period following the date of grant subject to the Reporting Person's continuous service on the Board through each such vesting date.
- [F2]The option vests monthly over six (6) months from the date of grant subject to the optionee's continued service to the Company.